Background: Variation in pain intensity and magnitude of disability among patients with musculoskeletal illness is largely accounted for by variations in symptoms of depression, catastrophic thinking, and heightened illness concern. It is possible that patients with greater stress, distress, and less effective coping strategies might be more likely to seek the use of Complementary Health Approaches (CHA). This study addressed the primary null hypothesis that there are no demographic, illness-related, or psychological factors associated with CHA use among patients with upper extremity illness. Methods: A cohort of 170 patients completed a web-based Complementary and Alternative Medicine (CAM) questionnaire the Patient Reported Outcomes Measurement Information System (PROMIS) Depression and Pain Interference questionnaires. We evaluated differences between patients who sought CAM treatment regarding the PROMIS Pain Interference and PROMIS Depression scores. Ninety-four patients (56%) use or plan to use CAM treatment. A CAM provider was consulted by 61 patients (37%): most commonly a massage therapist (30/61), chiropractor (26/61), or acupuncturist (14/61). Results: In bivariate analysis patients who sought CAM reported greater average PROMIS Pain Interference than those who did not. In multivariable logistic regression, CAM use was associated with a higher Pain Interference Score and the specific surgeon. Conclusion: In conclusion, CHA use is prevalent amongst orthopaedic patients and associated with less effective coping strategies. Orthopaedic surgeons might consider asking patients about CHA use and determining whether those patients are interested in cognitive behavioral therapy. Keywords: biopsychosocial model of illness, complementary and alternative medicine, orthopaedic surgery, pain interference, upper extremity illness
Introduction
Complementary health approaches (CHA) are health care approaches developed outside mainstream conventional medicine. 15 The most commonly used CHA among adults in the United States of America are nonvitamin, nonmineral, natural products (17.7%), deep breathing exercises (12.7%), meditation (9.4%), chiropractic or osteopathic manipulation (8.6%), massage (8.3%), and yoga (6.1%). 2, 11 In a survey of arthritis patients, more than 80% used some form of CHA to help treat their arthritis symptoms. 4 Although the CHA costs are a small fraction of total health care spending in the United States, the costs are comparable with the out-of-pocket costs for conventional physician services and pharmaceutical drug use. 2 Symptom intensity and magnitude of disability vary widely among patients with musculoskeletal illness. 16 This variation seems best explained within the biopsychosocial model of illness that accounts for psychological, biological, and sociological factors rather than the biomedical model, which focuses mostly on pathophysiology. Variation in pain intensity and magnitude of disability among patients with musculoskeletal illness are accounted for largely by variations in symptoms of depression, catastrophic thinking, and heightened illness concern. 16 Psychological factors are also strongly associated with less specific illnesses. 16 It is possible that patients with greater stress, distress, and less effective coping strategies might be more likely to consider CHA use.
Cognitive behavior therapy (CBT) is used to replace maladaptive patient coping skills, cognitions, emotions, and behaviors with more adaptive ones. From the biopsychosocial model of illness, CHA use in orthopedic patients may be filling a gap in care that could be enhanced by the substitution of CBT. 6 Numerous studies have shown that CBT benefits a diverse patient population from orthopedic patients with chronic pain to children and adolescents with depression and suicidality. 3, 13 The underreferral of orthopedic patients to CBT could be contributing to an increase in the use of CHA. 3 This study addressed the primary null hypothesis that there are no demographic, illness-related, or psychological factors associated with CHA use among patients with upper extremity illness.
Patients and Methods

Study Design
After the Institutional Review Board approval for this singlecenter prospective cohort study, we included 170 new and return patients presenting to an outpatient hand surgery office. Between June 2014 and October 2014, on the days when the research was present in the office, all adult, nonpregnant patients who were fluent in English were invited to participate prior to their visit with 1 of 2 hand surgeons. After informed consent, participants were then asked to complete the following questionnaires: demographics (age, sex, education), illness characteristics (diagnosis, duration of symptoms, prior treatments), the Complementary and Alternative Medicine (CAM) questionnaire (to assess CHA), and the Patient Reported Outcomes Measurement Information System (PROMIS) Depression and Pain Interference questionnaires. Data were collected using Assessment Center, a web-based data collection tool, with computer adaptive testing (CAT) 7,9 capabilities, using a tablet computer.
Outcome Measures
Psychological status was assessed with 2 questionnaires: the PROMIS Pain Interference and PROMIS Depression. Higher PROMIS Pain Interference scores address less effective coping strategies by measuring the degree to which pain limits or interferes with physical, mental, and social activities. 1, 12 Higher PROMIS Depression scores reflect increased symptoms of depression. For both the PROMIS Pain Interference and PROMIS Depression questionnaires, a score of 50 represents the norm of the US population and every 10 points is a standard deviation from the norm.
The CAM questionnaire was a modified version of the one used by Callahan et al. 4 We excluded vitamins and minerals and added additional CAM therapies based on the National Health Statistics Reports on Complementary and Alternative Medicine use in the United States. 15 Patients were asked whether they have ever used CAM therapies, are currently using CAM therapies, and if they plan to continue CAM therapies for the treatment of their upper extremity illness. Patients who indicate they used any of the CAM therapies listed on the CAM questionnaire were considered CAM users.
Statistical Analysis
A priori power analyses using G*Power demonstrated that enrolling 170 patients would provide 80% statistical power to detect a 0.5 effect size difference (α of .05) between patients who do and do not use CAM, anticipating that about one-quarter of the patients would be CAM users. In bivariate analysis, Fisher's Exact test was used to compare dichotomous and categorical variables and an unpaired t test was used for continuous variables. The t test was used to evaluate the differences between patients who sought CAM treatment regarding the PROMIS Pain Interference and PROMIS Depression scores. Multivariable logistic regression was used to assess if CAM treatment was independently associated with factors significant in bivariate analysis (P ≤ .05).
Participants
One hundred seventy of 178 eligible patients were enrolled. Two patients decided to opt out while completing the questionnaire and we lost the Internet connection for 1, resulting in a cohort of 167 patients (Table 1) . Missing data ("educational status" in 1 patient and prior treatment in 2) were identified in the medical record.
Ninety-four patients (56%) use or plan to use CAM treatment in regard to their upper extremity condition. A CAM provider was consulted by 61 patients (37%): most commonly a massage therapist (30/61), chiropractor (26/61), or acupuncturist (14/61) (see Table 2 ).
Results
In bivariate analysis patients who sought CAM had a significantly greater average PROMIS Pain Interference (mean: 58, SD ±7.6) than those who did not (mean: 55, SD ±7.3; P = .017; Table 3 ). PROMIS Depression did not differ between patients seeking CAM and those who did not (P = .088; Table 3 ). PROMIS Pain Interference, education, and specific surgeon met the criterion for entry into the multivariable model. Accounting for interactions between variables using multivariable logistic regression, CAM use was associated with a higher Pain Interference score (odds ratio [OR] 1.1, standard error [SE] ±0.024, 95% confidence interval [95% CI], 1.01-1.1, P = .023) and the specific surgeon seen (OR: 2.9, SE ±1.0, 95% CI, 1.5-5.7, P = .01; Table 4 ). 
Discussion
The variation among symptom intensity and magnitude of disability is best explained by the biopsychosocial model of illness. Patients with greater stress, distress, and less effective coping strategies might be more likely to consider CHA use. This study addressed the primary null hypothesis that there are no demographic, illness-related, or psychological factors associated with CHA use among patients with upper extremity illness. This study needs to be interpreted with its limitations in mind. First, all of the patients included in our study lived in the United States and were enrolled in 1 hand surgery clinic; therefore, we were not able to assess culture-related discrepancies in seeking alternative medicine. Second, the use of CHA reported by patients may not have been specific to their upper extremity condition. It might be helpful to be very specific both about the condition and the time points of use of CHA. 4, 8 Third, the intensity of CHA use remains unknown. We did not distinguish regular versus 1-time, or possible use.
We found that 56% of hand surgery outpatients use or planned to use CHA in the treatment of their upper extremity illness. This is consistent with recent studies suggesting that patients across a wide range of orthopedic practices are using CHA in addition to traditional Western medical practices. 5, 11, 14 Our finding that patients who sought CHA had less effective coping strategies (greater average PROMIS Pain Interference scores) than those who did not seek CHA is consistent with recent research conducted suggesting that the use of CHA in cancer patients is more prevalent among patients who suffer from fears, uncertainties, and dissatisfaction. 10 Comparing the average PROMIS Pain Interference scores of patients who did and did not use CHA (mean: 58, SD ±7.6) than those who did not (mean: 55, SD ±7.3; P = .017) showed a meaningful difference on the PROMIS instrument as compared with the standard deviation. CHA use might reflect a passivity and helplessness where an active role in optimizing self-efficacy would increase health. CHA may be filling a gap that might also be addressed by mind-body treatments such as CBT that have been proven to alter the disease course in a diverse patient population. 3, 6, 13 Our data showed that patients were 2.9 times more likely to use CAM depending on which provider they were treated by ( Table 3) . No explanation was identified to explain this variation in the data. The difference in CHA use among providers may influence how our data reflect the use of CHA among orthopedic patients in the general population. Based on the orthopedic surgeon, patients may be more or less inclined to pursue CHA. Future work should identify if patients are more likely to use CHA due to specific differences in physician practice.
These findings are important as in 2007 it was estimated that approximately 11.2% (US $33.9 billion) of the total out-of-pocket health care expenditures in the United States were on CHA. 2 Each year the US public makes more than 300 million visits to CHA providers. In 2007, the public spent US $14.8 billion out of pocket to purchase nonvitamin, nonmineral, natural products, or approximately 31% of the amount of out-of-pocket health care costs spent on prescription drug use. In addition, the public spent US $12.4 billion out of pocket on visits to CHA providers, or 25% of the out-of-pocket costs for conventional physician services.
In conclusion, this study revealed that CHA use is prevalent among orthopedic patients and associated with higher PROMIS Pain Interference scores. Patients who are interested in CHA might also be interested in and benefit from CBT. Future research might address the relative benefit of CHA treatments compared with CBT.
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